Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14% |
| 2 | Energy | 11.19% |
| 3 | Financials | 8.75% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENT
2051
DELISTED
Global Eagle Entertainment Inc.
ENT
| $1.53M | ﹤0.01% |
4,714
-5,968
| -56% | -$1.99M |
|
2052
Supernus Pharmaceuticals
SUPN
$2.7B
| $1.53M | ﹤0.01% |
90,291
-333,647
| -79% | -$4.75M |
|
|
BRKL
2053
DELISTED
Brookline Bancorp
BRKL
| $1.53M | ﹤0.01% |
135,701
+68,321
| +101% | +$744K |
|
2054
Clear Channel Outdoor Holdings
CCO
$1.22B
| $1.53M | ﹤0.01% |
151,124
+79,522
| +111% | +$867K |
|
|
CIVI
2055
DELISTED
Civitas Solutions, Inc.
CIVI
| $1.53M | ﹤0.01% |
71,646
-39,627
| -36% | -$818K |
|
2056
CALL
Sarepta Therapeutics
SRPT
$1.64B
| $1.52M | ﹤0.01% |
50,000
| – | – |
|
|
ETP
2057
DELISTED
Energy Transfer Partners, L.P.
ETP
| $1.52M | ﹤0.01% |
40,000
-84,000
| -68% | -$3.43M |
|
|
SIOX
2058
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.52M | ﹤0.01% |
+9,322
| New | +$1.58M |
|
|
AEUA
2059
DELISTED
Anadarko Petroleum Corporation
AEUA
| $1.51M | ﹤0.01% |
+30,000
| New | +$1.52M |
|
|
LIOX
2060
DELISTED
Lionbridge Technologies
LIOX
| $1.51M | ﹤0.01% |
245,069
-24,701
| -9% | -$144K |
|
|
KAMN
2061
DELISTED
Kaman Corp
KAMN
| $1.51M | ﹤0.01% |
35,946
-43,554
| -55% | -$1.84M |
|
2062
Realty Income
O
$61.1B
| $1.5M | ﹤0.01% |
+34,816
| New | +$1.59M |
|
|
SGEN
2063
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.5M | ﹤0.01% |
30,901
-754,904
| -96% | -$31.2M |
|
|
SD
2064
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $1.49M | ﹤0.01% |
1,694,097
+1,046,677
| +162% | +$1.54M |
|
2065
Palisade Bio
PALI
$341M
| $1.47M | ﹤0.01% |
+1
| New | +$2.18M |
|
2066
Coca-Cola Femsa
KOF
$22.5B
| $1.47M | ﹤0.01% |
18,515
-3,436
| -16% | -$280K |
|
2067
CALL
Lumen
LUMN
$6.43B
| $1.47M | ﹤0.01% |
+50,000
| New | +$1.7M |
|
2068
Great Southern Bancorp
GSBC
$878M
| $1.47M | ﹤0.01% |
34,825
+12,008
| +53% | +$479K |
|
|
ABCO
2069
DELISTED
Advisory Board Co
ABCO
| $1.47M | ﹤0.01% |
26,852
-18,045
| -40% | -$931K |
|
|
IL
2070
DELISTED
IntraLinks Holdings Inc.
IL
| $1.47M | ﹤0.01% |
123,237
+6,998
| +6% | +$74.1K |
|
2071
VeriSign
VRSN
$26.3B
| $1.47M | ﹤0.01% |
23,773
+10,113
| +74% | +$652K |
|
2072
Aecom
ACM
$9.46B
| $1.47M | ﹤0.01% |
+44,307
| New | +$1.46M |
|
2073
DNOW Inc
DNOW
$2.44B
| $1.46M | ﹤0.01% |
73,248
-29,637
| -29% | -$677K |
|
|
BMTC
2074
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.45M | ﹤0.01% |
47,940
+21,359
| +80% | +$645K |
|
|
AXLL
2075
CALL
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $1.44M | ﹤0.01% |
+40,000
| New | +$1.6M |
|
Similar funds
Millennium Management's Q2 2015 Portfolio in Review
As of Q2 2015, Millennium Management held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Millennium Management's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Energy and Financials.
- Millennium Management's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Millennium Management added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Millennium Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Millennium Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Millennium Management's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Millennium Management opened 780 new positions and closed 1,034 in Q2 2015.
- Millennium Management's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.